LOX and breast cancer: Recent studies indicated that hypoxic mammary tumors secret lysyl oxidase (LOX) to recruit CD11b+ myeloid cell at metastasis sites and these cells produce MMP-2 to disport collagene IV in experimental breast cancer metastasis models.